ZA200206318B - Modulation of bone formation. - Google Patents

Modulation of bone formation.

Info

Publication number: ZA200206318B
Authority: ZA; South Africa
Prior art keywords: modulation; bone formation; bone; formation
Prior art date: 2000-02-15

Application number

ZA200206318A

Other languages

English (en)

Inventor

Andrew Scutt

Karen Still

Original Assignee

Univ Sheffield

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-15

Filing date

2002-08-07

Publication date

2003-11-07

2002-08-07 Application filed by Univ Sheffield filed Critical Univ Sheffield

2003-11-07 Publication of ZA200206318B publication Critical patent/ZA200206318B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)

ZA200206318A 2000-02-15 2002-08-07 Modulation of bone formation. ZA200206318B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0003310.0A GB0003310D0 (en)	2000-02-15	2000-02-15	Bone formation

Publications (1)

Publication Number	Publication Date
ZA200206318B true ZA200206318B (en)	2003-11-07

Family

ID=9885521

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200206318A ZA200206318B (en)	2000-02-15	2002-08-07	Modulation of bone formation.

Country Status (18)

Country	Link
US (1)	US20030139372A1 (xx)
EP (1)	EP1259233A1 (xx)
JP (1)	JP2003522787A (xx)
KR (1)	KR20020093808A (xx)
CN (1)	CN1430512A (xx)
AU (1)	AU3212101A (xx)
BR (1)	BR0108344A (xx)
CA (1)	CA2399810A1 (xx)
CZ (1)	CZ20022741A3 (xx)
GB (1)	GB0003310D0 (xx)
HK (1)	HK1049618A1 (xx)
HU (1)	HUP0204511A3 (xx)
IL (1)	IL151243A0 (xx)
MX (1)	MXPA02007901A (xx)
NO (1)	NO20023837L (xx)
NZ (1)	NZ520764A (xx)
WO (1)	WO2001060355A1 (xx)
ZA (1)	ZA200206318B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6716842B2 (en)	2002-04-05	2004-04-06	Warner-Lambert Company, Llc	Antidiabetic agents
CA2525695A1 (en) *	2003-05-28	2004-12-09	Isao Chinen	Compositions and foods and drinks containing higher fatty acid derivative
KR20060056377A (ko) *	2003-08-13	2006-05-24	카이론 코포레이션	Ｇｓｋ-3 억제제 및 그것의 사용
ATE542793T1 (de) *	2003-09-19	2012-02-15	Janssen Pharmaceutica Nv	4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga
DE602004028500D1 (de) *	2003-09-19	2010-09-16	Janssen Pharmaceutica Nv	4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga
US20090137614A1 (en) *	2005-05-27	2009-05-28	Shionogi & Co., Ltd.	Pharmaceutical combination comprising vitamin k
NO20053517L (no) *	2005-07-18	2007-01-19	Thia Medica As	Anvendelse av lipidsenkende midler
US20090163481A1 (en) *	2007-12-13	2009-06-25	Murphy Brian J	Ppar-delta ligands and methods of their use
EP2237777A4 (en) *	2008-01-02	2011-03-30	Marine Bio Co Ltd	COMPOSITIONS AND METHOD FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
WO2010137944A1 (en)	2009-05-27	2010-12-02	N.V. Nutricia	Treatment of hypercalcaemia
JP2015517087A (ja) *	2012-02-15	2015-06-18	ビーエーエスエフソシエタス・ヨーロピアＢａｓｆＳｅ	骨障害を評価するための手段及び方法
US9763911B2 (en)	2013-12-12	2017-09-19	Mayo Foundation For Medical Education And Research	Prostacyclin compositions for regulation of fracture repair and bone formation
CN105327333B (zh) *	2015-10-30	2018-09-07	大连大学	可促进牙种植体周围成骨的口腔施用组合物及其制剂
CN110433156A (zh) *	2019-08-27	2019-11-12	成都元素平衡生物科技有限公司	芝麻素在成骨分化中的新应用
WO2021046081A1 (en) *	2019-09-05	2021-03-11	Rush University Medical Center	Methods and compositions for treatment of demyelinating disorders
CN111789833A (zh) *	2020-08-31	2020-10-20	苏州大学	2-溴棕榈酸在制备防治骨丢失相关疾病的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5312814A (en) *	1992-12-09	1994-05-17	Bristol-Myers Squibb Co.	α-phosphonocarboxylate squalene synthetase inhibitors
EP0783888A1 (en) *	1995-12-26	1997-07-16	Sankyo Company Limited	Use of troglitazone and related thiazolidinediones in the manufacture of a medicament for the treatment and prophylaxis of osteoporosis
JPH09295936A (ja) *	1996-04-30	1997-11-18	Kowa Techno Saac:Kk	人工透析患者の骨疾患治療用外用剤
US5804210A (en) *	1996-08-07	1998-09-08	Wisconsin Alumni Research Foundation	Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein
US5925657A (en) *	1997-06-18	1999-07-20	The General Hospital Corporation	Use of PPARγ agonists for inhibition of inflammatory cytokine production
WO1999024032A1 (en) *	1997-11-10	1999-05-20	Novo Nordisk A/S	Transdermal delivery of 3,4-diarylchromans
GB9824614D0 (en) *	1998-11-11	1999-01-06	Glaxo Group Ltd	Chemical compounds

2000
- 2000-02-15 GB GBGB0003310.0A patent/GB0003310D0/en not_active Ceased
2001
- 2001-02-15 CA CA002399810A patent/CA2399810A1/en not_active Abandoned
- 2001-02-15 KR KR1020027010501A patent/KR20020093808A/ko not_active Ceased
- 2001-02-15 JP JP2001559453A patent/JP2003522787A/ja not_active Abandoned
- 2001-02-15 HU HU0204511A patent/HUP0204511A3/hu unknown
- 2001-02-15 MX MXPA02007901A patent/MXPA02007901A/es unknown
- 2001-02-15 US US10/203,695 patent/US20030139372A1/en not_active Abandoned
- 2001-02-15 HK HK03101711.3A patent/HK1049618A1/zh unknown
- 2001-02-15 NZ NZ520764A patent/NZ520764A/en unknown
- 2001-02-15 CN CN01807911A patent/CN1430512A/zh active Pending
- 2001-02-15 CZ CZ20022741A patent/CZ20022741A3/cs unknown
- 2001-02-15 WO PCT/GB2001/000626 patent/WO2001060355A1/en not_active Ceased
- 2001-02-15 BR BR0108344-9A patent/BR0108344A/pt not_active IP Right Cessation
- 2001-02-15 EP EP01904207A patent/EP1259233A1/en not_active Withdrawn
- 2001-02-15 AU AU32121/01A patent/AU3212101A/en not_active Abandoned
- 2001-02-15 IL IL15124301A patent/IL151243A0/xx unknown
2002
- 2002-08-07 ZA ZA200206318A patent/ZA200206318B/xx unknown
- 2002-08-14 NO NO20023837A patent/NO20023837L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB0003310D0 (en)	2000-04-05
NZ520764A (en)	2004-05-28
WO2001060355A1 (en)	2001-08-23
HK1049618A1 (zh)	2003-05-23
EP1259233A1 (en)	2002-11-27
CZ20022741A3 (cs)	2003-03-12
CN1430512A (zh)	2003-07-16
US20030139372A1 (en)	2003-07-24
HUP0204511A2 (en)	2003-05-28
KR20020093808A (ko)	2002-12-16
BR0108344A (pt)	2003-03-11
HUP0204511A3 (en)	2004-11-29
CA2399810A1 (en)	2001-08-23
NO20023837D0 (no)	2002-08-14
NO20023837L (no)	2002-10-14
AU3212101A (en)	2001-08-27
MXPA02007901A (es)	2004-09-10
JP2003522787A (ja)	2003-07-29
IL151243A0 (en)	2003-04-10

Publication	Publication Date	Title
GB2383706B (en)	2005-03-30	Modulation control
ZA200404306B (en)	2005-06-15	3'-prodrugs of 2'-deoxy-beta-L-nucleosides.
GB0014079D0 (en)	2000-08-02	Orthopaedic implant
AU2001229583A1 (en)	2001-09-12	Bone drill
ZA200204020B (en)	2003-11-21	Use of anti-CTLA-4-antibodies.
AU2001289085A1 (en)	2002-04-02	Antisense modulation of flip-c expression
ZA200205887B (en)	2003-07-23	Liver tissue source.
ZA200206318B (en)	2003-11-07	Modulation of bone formation.
GB0011244D0 (en)	2000-06-28	Tissue regrafting
AU2001227847A1 (en)	2001-07-31	Antisense modulation of pepck-cytosolic expression
AU2002366788A8 (en)	2003-07-09	Antisense modulation of ship-1 expression
GB0126781D0 (en)	2002-01-02	Modulation
GB0124321D0 (en)	2001-11-28	Modulation determination
AU2002357102A8 (en)	2003-06-30	Antisense modulation of cd36l1 expression
AU2001287136A1 (en)	2002-03-22	Antisense modulation of glioma-associated oncogene-1 expression
AU2001280588A1 (en)	2002-01-30	Methods of modulating angiogenesis
AU7373801A (en)	2001-12-24	Expression modulating sequences
AU2002347809A1 (en)	2003-04-22	Antisense modulation of inhibitor-kappa b kinase-gamma expression
AU2002245089A1 (en)	2002-07-24	Antisense modulation of cytohesin-1 expression
AU2001256507A1 (en)	2001-11-26	Modulation
ZA200102132B (en)	2001-11-21	Train formation.
AU6465700A (en)	2001-08-07	Expanding bone implants
GB0015131D0 (en)	2000-08-09	Signal modulation
GB0126771D0 (en)	2002-01-02	Modulation
GB0126808D0 (en)	2002-01-02	Modulation